Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,501.20
(
0.15%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
111.76
(
-0.55%
)
Bitcoin
76,007.42
(
0.30%
)
News Focus
News Focus
Post# of 257470
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122909
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 224674

Monday, 04/15/2019 8:41:16 PM

Monday, April 15, 2019 8:41:16 PM

Post# of 257470

Despite Spark getting approval, I find all Gene Therapy eye indications difficult to invest in! In addition to mediocre results, the level of competition is extremely high especially Wet AMD.

I’ve sidestepped that problem by not investing in gene-therapy companies at all :- )

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today